FDA Greenlights 'Breakthrough' Alzheimer's Drug Amid Risk and Cost Concerns
Leqembi, a breakthrough drug for Alzheimers disease, as received the FDA’s nod for use, but medical experts caution about potential side effects, and call for training medical professionals before use.
United States Drug Administration Side Effectsleqembi Most Americans Chiquita Brooks Lasure Certain Medicare
Source: sputnikglobe.com